• Follow us
  • EN
    Flag Indonesia ID
    Flag English EN
Untitled design (6)
  • About Us
    • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Recruitment
  • PPID
  • Contact Us
search

Explanation of Bio Farma with regard to Counterfeit Vaccine

Monday, 4 July 2016

Bandung, June 30, 2016, 10.00 Local Time

In response to arising news related to suspected counterfeit vaccine, below is Bio Farma’s explanation:

  1. Bio Farma has coordinated with the National Police’s Criminal Investigation Agency (Bareskrim), Ministry of Health, the Drug and Food Monitoring Agency (BPOM) and authorized Distributor of Bio Farma Vaccine.
  2. Based on physical, packaging and result of latoratory test observation, the suspected counterfeit vaccine is ORIGINAL, NOT COUNTERFEITED.
  3. Vaccines produced by Bio Farma used by the Government for National Immunization Program are Pentabio (DTP-HB-Hib), DT, Td, TT, Hepatitis B, Measles, Polio and BCG Vaccines. In ensuring safety, efficacy, and quality of vaccines, all vaccines produced by Bio Farma are tested for Release from the Drug and Food Monitoring Agency ,Badan POM and in compliance with the standards of the World Health Organization (WHO).
  4. The community is encouraged not to have doubt to have their children immunized using vaccines as programmed by the Government, either at Hospital, Community Health Center, neighbourhood health center, or clinic.
  5. Vaccine is distributed in formal distribution channel. Bio Farma Vaccine for national immunization program is distributed via Provincial Health Offices and, for private sector, distributed via authorized distributor by implementing consistent cold chain and Good Distribution Practice (CDOB) thus the quality, safety and effectiveness are maintained.
  6. Bio Farma fully supports Bareskrim POLRI for further handling and investigation of counterfeit vaccine case.
  7. As an anticipation and evaluation measure to prevent dissemination of counterfeit vaccine, each healthcare facility and immunization center of the Government and private sector should have management and control facility for vaccine waste/ used vaccine container or expired vaccine.
  8. For serum and diagnostic products produced by Bio Farma such as BIOSAT (Anti-Tetanus Serum), BIOSAVE (Anti-Snake Venom Serum), and Tuberculin PPD that are counterfeited, are currently handled by Bareskrim POLRI.

*****---*****

 

Overview of Bio Farma

Bio Farma is a State-Owned Enterprise that is 100% owned by the Government, a Vaccine and Antisera manufacturer. Established on August 6, 1890. During 126 years of its establishment, Bio Farma has contributed to improve the quality of the people’s lives, both residing in Indonesia and overseas. More than 130 countries have used Bio Farma products, primarily developing countries, and 50 of them are countries united in the Organization of Islamic Cooperation (OKI). The production of Bio Farma Vaccines has met standard established by The National Agency of Drug and Food Control (BPOM) and the World Health Organization (WHO). This production is in compliance with a series of very strict regulation, from selection of raw material originated from qualified vendor, raw material storing, production process, production facility and competence of Human Resources that must be qualified and well trained and the equipment must be calibrated and validated regularly within specific period. With production capacity more than 3.2 Billion doses annually, Bio Farma has fulfilled the need for vaccine nationally and internationally via WHO and UNICEF. Under the Dedicated to Improve Quality of Life philosophy, Bio Farma plays active role in improving the availability and production self-sufficiency of Vaccine for developing countries and Islamic countries in maintaining Global Health Security. For further information, go to www.biofarma.co.id

 

*****

 

For further information, please contact:

Corporate Communications

Email : lala@biofarma.co.id ; corcom@biofarma.co.id

Bio Farma

Jl. Pasteur No. 28 Bandung

Phone : 62 22 2033755

Fax : 62 22 2041306

 

  • Share to:
Download

Latest News

WhatsApp Image 2024-07-26 at 15.00.55 (1)
Friday, 26 July 2024
Turut Peringati Hari Konservasi Alam Nasional 2024 : Bio Farma Lepasliarkan Owa Jawa dan Surili di Cagar Alam Gunung Tilu, Jabar
JOKOWI INDOVAC
Wednesday, 23 November 2022
IndoVac Can Be Used by the Elderly for the Second Booster of the Covid-19 Vaccine
IDC awards 2022
Friday, 18 November 2022
Bio Farma Wins IDC Future Enterprise Awards 2022 Indonesia
View more

Logo biofarma

Call Center 1500810

Head Office

Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
+62 22-2033755
+62 22 - 2041306
mail@biofarma.co.id

Breeding Facility Bio Farma

Jl. Kolonel Masturi Kav 10. Desa Kertawangi kec. Cisarua
Jawa Barat

Bio Farma Representative Office

Gd. Pakarti centre Lantai 7
Jln. Tanah Abang 3 no.23-27
Jakarta Pusat

Information

  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career

 

  • Contact Us
  • E-PPID
  • Announcement
  • Media Release

Quick Links

  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2026. All Rights Reserved by Bio Farma

Change Language

EN
  • About Us
    • Company Profile
      • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Career
    • Recruitment
  • PPID
  • Contact Us
  • Follow us
Change Language
  • Flag Indonesia ID
  • Flag English EN